IP Library › Granted Patent US 12,539,228
Granted Patent B2
US 12,539,228 · App. 18/524,681 · Granted Feb 3, 2026

Inserter

Inventors: Heikki Lyytikäinen (Naantali, FI); Ilkka Jutila (Littoinen, FI); Ulla Calvo Alonso (Piispanristi, FI); Harri Jukarainen (Kuusisto, FI); Taina Träder (Littoinen, FI); Andrew Macleod (Cambridge, GB); Michael Noble (London, GB); David Whitaker (London, GB)
Assignee: Bayer Oy
A61F6/18A61F6/142A61M31/00A61F6/144
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,539,228
App. No.
18/524,681
Granted
Feb 3, 2026
Kind
B2
Abstract

The present invention relates to an inserter for an intrauterine system comprising a handle ( 3 ), and an insertion tube ( 6 ) having a first end and a second end, and being arranged in connection with the handle. The inserter is characterized in that the first end of the insertion tube ( 6 ) comprises at least one frame slot for receiving a frame of the intrauterine system. The invention also relates to a kit comprising an inserter according to the present invention and an intrauterine system, wherein the intrauterine system ( 1 ) comprises a therapeutic component ( 1 b ) and a continuous, closed frame ( 1 a ), the therapeutic component ( 1 b ) being connected to the frame ( 1 a ) at least one point, and therapeutic component ( 1 b ) of the intrauterine system ( 1 ) is at least mainly arranged inside the first end of the insertion tube ( 6 ) and the frame ( 1 a ) of the intrauterine system ( 1 ) is at least mainly arranged outside the first end of the insertion tube ( 6 ).

Claims (44)

1 . A kit comprising:

an intrauterine system comprising:

a reservoir containing a hormone; and

a removal string attached to the intrauterine system; and

an inserter comprising:

a handle comprising a movable slider arranged in a longitudinal opening;

a plunger attached to the handle;

an insertion tube attached to the slider; and

a lock arranged inside the handle, the locking means lock being controllable by the slider,

wherein the lock comprises:

a first locking part and a second locking part movably mounted inside the handle and arranged in a first position of the slider to be essentially in contact with each other to form a blocking and lock the intrauterine system in relation to the plunger via the removal string; and

a first protrusion and a second protrusion arranged inside the handle,

wherein the first and second protrusions are arranged to move the first and second locking parts in response to movement of the slider to a second position and release the removal string and intrauterine system.

2 . The kit of claim 1 , wherein the inserter further comprises an adjustable flange arranged on the insertion tube.

3 . The kit of claim 2 , wherein the hormone is levonorgestrel.

4 . The kit of claim 1 , wherein the removal string is contained wholly within the insertion tube and the handle.

5 . The kit of claim 4 , wherein the hormone is levonorgestrel.

6 . The kit of claim 1 , wherein the intrauterine system further comprises image enhancing means.

7 . The kit of claim 6 , wherein the hormone is levonorgestrel.

8 . The kit of claim 1 , wherein the hormone is levonorgestrel.

9 . A method of preventing pregnancy or providing contraception in a patient, comprising:

(a) providing an intrauterine system having a reservoir containing a hormone and a removal string attached to the intrauterine system;

(b) holding an inserter in one hand, the inserter comprising:

a handle comprising a movable slider arranged in a longitudinal opening;

a plunger attached to the handle;

an insertion tube attached to the slider; and

a lock arranged inside the handle, the lock being controllable by the slider,

wherein the lock comprises:

a first locking part and a second locking part movably mounted inside the handle and arranged in a first position of the slider to be essentially in contact with each other to form a blocking and lock the intrauterine system in relation to the plunger via the removal string; and

a first protrusion and a second protrusion arranged inside the handle,

wherein the first and second protrusions are arranged to move the first and second locking parts in response to movement of the slider to a second position and release the removal string and intrauterine system;

(c) introducing the inserter into a uterus of the patient with the one hand; and

(d) moving the slider with one digit of the one hand, thereby releasing the removal string and intrauterine system within the uterus.

10 . The method of claim 9 , where the inserter further comprises an adjustable flange arranged on the insertion tube.

11 . The method of claim 10 , further comprising:

sounding the uterus to predetermine a depth for placement of the intrauterine system; and

adjusting the flange to correspond to the predetermined depth.

12 . The method of claim 11 , wherein the hormone is levonorgestrel.

13 . The method of claim 10 , wherein the hormone is levonorgestrel.

14 . The method of claim 9 , wherein the removal string is contained wholly within the insertion tube and the handle.

15 . The method of claim 14 , wherein the hormone is levonorgestrel.

16 . The method of claim 9 , wherein the intrauterine system further comprises image enhancing means.

17 . The method of claim 16 , wherein the hormone is levonorgestrel.

18 . The method of claim 9 , wherein the hormone is levonorgestrel.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2023
From: LYYTIKÄINEN, HEIKKI; JUTILA, ILKKA; ALONSO, ULLA CALVO; JUKARAINEN, HARRI; TJÄDER, TAINA; MACLEOD, ANDREW; NOBLE, MICHAEL; WHITAKER, DAVID
To: BAYER OY
Reel/Frame 065718/0135 →
Priority Claims (2)
FI 20085870 · Sep 17, 2008 · national
FI 20085871 · Sep 17, 2008 · national
Continuity (8)
Continuation 16792748 · Feb 17, 2020
Continuation 15891187 · Feb 7, 2018
Continuation 15470870 · Mar 27, 2017
Continuation 15245042 · Aug 23, 2016
Continuation 14088329 · Nov 22, 2013
Continuation 13771066 · Feb 19, 2013
Continuation 13119401
Related Publication 20240173163A1 · May 30, 2024
References Cited (210)
US 3533406A · Tatum · 1970 [cited by applicant]
US 3656483A · Rudel · 1972 [cited by applicant]
US 3783861A · Abramson · 1974 [cited by applicant]
US 3794025A · Lerner · 1974 [cited by applicant]
US 3896819A · Zaffaroni et al. · 1975 [cited by applicant]
US 3902483A · Place et al. · 1975 [cited by applicant]
US 3918444A · Hoff et al. · 1975 [cited by applicant]
US 4143656A · Holmes · 1979 [cited by applicant]
US 4341728A · Robertson et al. · 1982 [cited by applicant]
US 4353363A · Sopena · 1982 [cited by applicant]
US 4413985A · Wellner et al. · 1983 [cited by applicant]
US 4562835A · Anderson · 1986 [cited by applicant]
US 4578075A · Urquhart et al. · 1986 [cited by applicant]
US 4578076A · Luukkainen et al. · 1986 [cited by applicant]
US 4655204A · Basuyaux · 1987 [cited by applicant]
US 4678463A · Millar · 1987 [cited by applicant]
US 4721105A · Wildemeersch · 1988 [cited by applicant]
US 4724832A · Strubel et al. · 1988 [cited by applicant]
US 4805628A · Fry et al. · 1989 [cited by applicant]
US 4949732A · Spoon et al. · 1990 [cited by applicant]
US 5146931A · Kurz · 1992 [cited by applicant]
US 5217450A · Pryor et al. · 1993 [cited by applicant]
US 5224493A · Sawan et al. · 1993 [cited by applicant]
US 5370129A · Diaz et al. · 1994 [cited by applicant]
US 5494047A · Van Os · 1996 [cited by applicant]
US 5785053A · Macandrew · 1998 [cited by examiner]
US 6056976A · Markkula et al. · 2000 [cited by applicant]
US 6103256A · Nabahi · 2000 [cited by applicant]
US 6119696A · Turin · 2000 [cited by applicant]
US 6278057B1 · Avellanet · 2001 [cited by applicant]
US 6299027B1 · Berge et al. · 2001 [cited by applicant]
US 6476079B1 · Jukarainen et al. · 2002 [cited by applicant]
US 6588429B1 · Wildemeersch · 2003 [cited by applicant]
US 6652548B2 · Evans et al. · 2003 [cited by applicant]
US D525705S · Luukkainen · 2006 [cited by applicant]
US 7252839B2 · Hallinen et al. · 2007 [cited by applicant]
US 7294135B2 · Stephens et al. · 2007 [cited by applicant]
US 7926488B2 · Luukkainen · 2011 [cited by applicant]
US 8573222B2 · Weintraub · 2013 [cited by applicant]
US D718435S · Deckman et al. · 2014 [cited by applicant]
US 9452082B2 · Lyytikainen et al. · 2016 [cited by applicant]
US 9615965B2 · Lyytikainen et al. · 2017 [cited by applicant]
US 9668912B2 · Jutila et al. · 2017 [cited by applicant]
US D791318S · Jutila et al. · 2017 [cited by applicant]
US 9707123B2 · Lyytikäinen et al. · 2017 [cited by applicant]
US D810289S · Jutila et al. · 2018 [cited by applicant]
US 10149784B2 · Jutila et al. · 2018 [cited by applicant]
US 10561524B2 · Lyytikäinen et al. · 2020 [cited by applicant]
US 10583035B2 · Lyytikäinen et al. · 2020 [cited by applicant]
US 10987244B2 · Jutila et al. · 2021 [cited by applicant]
US 11432958B2 · Lyytikäinen et al. · 2022 [cited by applicant]
US 20030028236A1 · Gillick et al. · 2003 [cited by applicant]
US 20040163650A1 · Lowe · 2004 [cited by examiner]
US 20040261799A1 · Mock · 2004 [cited by applicant]
US 20050178391A1 · Wildemeersch · 2005 [cited by applicant]
US 20050274384A1 · Tran et al. · 2005 [cited by applicant]
US 20070056591A1 · McSwain · 2007 [cited by applicant]
US 20070123904A1 · Stad et al. · 2007 [cited by applicant]
US 20070129734A1 · Jutila · 2007 [cited by applicant]
US 20080095825A1 · Lafont · 2008 [cited by applicant]
US 20090069890A1 · Suri et al. · 2009 [cited by applicant]
US 20090105794A1 · Ziarno et al. · 2009 [cited by applicant]
US 20090123522A1 · Browning · 2009 [cited by applicant]
US 20100049313A1 · Alon et al. · 2010 [cited by applicant]
US 20100168563A1 · Braver · 2010 [cited by applicant]
US 20100168756A1 · Dorn et al. · 2010 [cited by applicant]
US 20100186750A1 · Tran et al. · 2010 [cited by applicant]
US 20100280464A1 · De Graaff et al. · 2010 [cited by applicant]
US 20110017219A1 · De Graaff et al. · 2011 [cited by applicant]
US 20110056501A1 · Kortesuo et al. · 2011 [cited by applicant]
US 20110061659A1 · Cruzada et al. · 2011 [cited by applicant]
US 20110079226A1 · Sakhel · 2011 [cited by applicant]
US 20110146693A1 · Duesterberg et al. · 2011 [cited by applicant]
US 20110162656A1 · Jutila et al. · 2011 [cited by applicant]
US 20110166508A1 · Lyytikainen et al. · 2011 [cited by applicant]
US 20110172593A1 · Lyyikäinen et al. · 2011 [cited by applicant]
US 20110226257A1 · Lowe et al. · 2011 [cited by applicant]
US 20110238147A1 · Bennett et al. · 2011 [cited by applicant]
US 20130255695A1 · Jutila et al. · 2013 [cited by applicant]
US 20150107598A1 · Tal et al. · 2015 [cited by applicant]
US 20160217707A1 · Jutila · 2016 [cited by applicant]
US 20170027739A1 · Deckman et al. · 2017 [cited by applicant]
US 20170196728A1 · Lyytikainen et al. · 2017 [cited by applicant]
US 20170202701A1 · Tal et al. · 2017 [cited by applicant]
US 20200179159A1 · Lyytikäinen et al. · 2020 [cited by applicant]
US 20210298942A1 · Jutila et al. · 2021 [cited by applicant]
US 20220265465A1 · Jutila et al. · 2022 [cited by applicant]
US 20220265466A1 · Jutila et al. · 2022 [cited by applicant]
US 20220273487A1 · Jutila et al. · 2022 [cited by applicant]
CA 1033247 · 1978 [cited by applicant]
CN 1168626 · 1997 [cited by applicant]
CN 1377635 · 2002 [cited by applicant]
CN 201042478 · 2008 [cited by applicant]
CN 201104943Y · 2008 [cited by applicant]
CN 101360523 · 2009 [cited by applicant]
CN 201505207U · 2010 [cited by applicant]
DE 8712168 · 1987 [cited by applicant]
DE 29819558 · 1999 [cited by applicant]
DE 19815552 · 1999 [cited by applicant]
DE 29919662 · 2000 [cited by applicant]
EP 0191957 · 1986 [cited by applicant]
EP 0798999 · 1997 [cited by applicant]
EP 0948948 · 1999 [cited by applicant]
EP 1691740 · 2006 [cited by applicant]
ES 0234119 · 1987 [cited by applicant]
ES 0295117 · 1988 [cited by applicant]
FI 882466 · 1999 [cited by applicant]
FI 0080523 · 2008 [cited by applicant]
GB 1039011 · 1966 [cited by applicant]
GB 1403393 · 1975 [cited by applicant]
GB 1486994 · 1977 [cited by applicant]
GB 1543841 · 1979 [cited by applicant]
JP 2010510444 · 2010 [cited by applicant]
NL 8601570 · 1988 [cited by applicant]
SU 1377063 · 1988 [cited by applicant]
WO 9528901 · 1995 [cited by applicant]
WO 1995028901A1 · 1995 [cited by applicant]
WO 9618365 · 1996 [cited by applicant]
WO 199618365 · 1996 [cited by applicant]
WO 1996029026 · 1996 [cited by applicant]
WO 1999005958 · 1999 [cited by applicant]
WO 0000550 · 2000 [cited by applicant]
WO 2001013832 · 2001 [cited by applicant]
WO 03017971 · 2003 [cited by applicant]
WO 2003017971 · 2003 [cited by applicant]
WO 2005048893 · 2006 [cited by applicant]
WO 2007075086 · 2007 [cited by applicant]
WO 2010031899 · 2010 [cited by applicant]
WO 2010031900 · 2010 [cited by applicant]
WO 2010031900A1 · 2010 [cited by applicant]
WO 2010031902 · 2010 [cited by applicant]
WO 2010082197 · 2010 [cited by applicant]
WO 2010112095 · 2010 [cited by applicant]
WO 2011080164 · 2011 [cited by applicant]
USPTO Non-Final Office Action mailed in U.S. Appl. No. 13/119,401, Aug. 17, 2012. [cited by applicant]
USPTO Non-Final Office Action mailed in U.S. Appl. No. 13/771,066, May 22, 2013, 10 pages. [cited by applicant]
USPTO Final Office Action received for U.S. Appl. No. 14/088,329, Jan. 30, 2015, 18 pages. [cited by applicant]
USPTO Non-Final Office Action received for U.S. Appl. No. 14/088,329, Apr. 9, 2014, 19 pages. [cited by applicant]
USPTO Non-Final Office Action received for U.S. Appl. No. 14/088,329, Dec. 3, 2015, 19 pages. [cited by applicant]
USPTO Non-Final Office Action received in U.S. Appl. No. 13/857,134, Jul. 7, 2014, 19 pages. [cited by applicant]
USPTO Non-Final Office Action received for U.S. Appl. No. 13/119,397, Nov. 19, 2013, 19 pages. [cited by applicant]
EPO Notice of Opposition to European Patent No. EP2352470, Sep. 26, 2013, 19 pages. [cited by applicant]
USPTO Non-Final Office Action received in U.S. Appl. No. 14/590,969, Jan. 29, 2016, 20 pages. [cited by applicant]
USPTO Final Office Action received for U.S. Appl. No. 13/119,397, Jan. 12, 2016, 21 pages. [cited by applicant]
USPTO Non-Final Office Action received in U.S. Appl. No. 13/119,399, Oct. 4, 2012, 22 pages. [cited by applicant]
USPTO Non-Final Office Action received for U.S. Appl. No. 13/119,397, May 5, 2015, 23 pages. [cited by applicant]
EPO Reply to the Notice of Opposition to European Patent No. EP2352470, Apr. 25, 2014, 28 pages. [cited by applicant]
USPTO Final Office Action received for U.S. Appl. No. 13/119,397, Sep. 5, 2014, 28 pages. [cited by applicant]
PCT International Preliminary Report on Patentability mailed in PCT Application No. PCT/FI2011/050933, Apr. 30, 2013, 4 pages. [cited by applicant]
PCT International Preliminary Report on Patentability mailed in PCT Application No. PCT/FI2009/050733, Mar. 22, 2011, 6 pages. [cited by applicant]
PCT International Preliminary Report on Patentability mailed in PCT Application No. PCT/FI2009/050735, Mar. 22, 2011, 6 pages. [cited by applicant]
PCT International Search Report and Written Opinion mailed in PCT Application No. PCT/FI2011/050933, Mar. 5, 2012, 7 pages. [cited by applicant]
PCT International Search Report and Written Opinion mailed in PCT Application No. PCT/FI2009/050735, Dec. 10, 2009, 8 pages. [cited by applicant]
PCT International Search Report and Written Opinion mailed in PCT Application No. PCT/FI2009/050733, Dec. 23, 2009, 8 pages. [cited by applicant]
Johnson, et al., “Insertion and Removal of Intrauterine Devices”, American Family Physician, vol. 71, No. 1, Jan. 1, 2005, pp. 95-102. [cited by applicant]
merriam-webster.com, “adhesion”, Retrieved from Internet: https://www.merriam-webster.com/dictionary/adhesion, 1 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 16/813,340, Apr. 22, 2022, 10 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 13/882,264, Jul. 31, 2018, 10 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 14/590,969, Mar. 8, 2017, 10 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 13/771,066, May 22, 2013, 10 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 15/647,104, Oct. 18, 2019, 10 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 13/882,264, Apr. 6, 2017, 11 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 13/119,401, Aug. 17, 2012, 11 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 17/239,428, Jun. 21, 2023, 11 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 17/743,249, Sep. 8, 2023, 11 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 13/119,397, Apr. 5, 2017, 12 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 17/743,236, Aug. 10, 2023, 12 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 13/882,264, Nov. 28, 2017, 12 pages. [cited by applicant]
USPTO, Final Office Action for U.S. Appl. No. 13/882,264, Nov. 7, 2016, 13 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 17/743,236, Feb. 10, 2023, 14 pages. [cited by applicant]
USPTO, Final Office Action for U.S. Appl. No. 14/590,969, Jul. 20, 2016, 14 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 13/882,264, Mar. 24, 2016, 15 pages. [cited by applicant]
USPTO, Ex Parte Quayle Action for Design U.S. Appl. No. 29/558,312, Feb. 6, 2017, 16 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 15/589,789, Dec. 30, 2019, 17 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 15/589,789, May 29, 2019, 17 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 17/239,417, Dec. 22, 2022, 18 pages. [cited by applicant]
USPTO, Notice of Allowance for Design U.S. Appl. No. 29/605,236, Oct. 3, 2017, 19 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 17/239,417, Oct. 3, 2023, 19 pages. [cited by applicant]
USPTO, Final Office Action for U.S. Appl. No. 17/239,417, May 31, 2023, 21 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 15/470,870, Nov. 8, 2017, 25 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 17/743,213, Sep. 26, 2023, 26 pages. [cited by applicant]
USPTO, Final Office Action for U.S. Appl. No. 17/743,213, Jun. 14, 2023, 29 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 17/743,249, Feb. 8, 2023, 30 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 17/743,213, Jan. 26, 2023, 30 pages. [cited by applicant]
USPTO, Notice of Allowance for Design U.S. Appl. No. 29/558,312, Mar. 8, 2017, 5 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 15/245,042, Oct. 11, 2016, 6 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 16/792,748, Aug. 30, 2023, 7 pages. [cited by applicant]
USPTO, Ex Parte Quayle Action for U.S. Appl. No. 17/743,249, Jun. 27, 2023, 7 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 16/792,748, May 10, 2023, 7 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 16/792,748, May 20, 2022, 7 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 15/470,870, May 23, 2017, 7 pages. [cited by applicant]
USPTO, Final Office Action for U.S. Appl. No. 16/792,748, Nov. 29, 2022, 7 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 15/245,042, Feb. 10, 2017, 8 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 15/891,187, Jun. 21, 2019, 8 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 14/088,329, May 18, 2016, 8 pages. [cited by applicant]
USPTO, Final Office Action for U.S. Appl. No. 15/589,789, May 26, 2020, 8 pages. [cited by applicant]
USPTO, Non-final Office Action for Design U.S. Appl. No. 29/558,311, Oct. 24, 2017, 8 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 15/891,187, Oct. 9, 2019, 8 pages. [cited by applicant]
USPTO, Notice of Allowance for U.S. Appl. No. 15/589,789, Dec. 31, 2020, 9 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 15/891,187, Nov. 2, 2018, 9 pages. [cited by applicant]
USPTO, Non-final Office Action for U.S. Appl. No. 15/470,870, Apr. 17, 2017, 12 pages. [cited by applicant]
UPSTO, Non-final Office Action for U.S. Appl. No. 17/743,213, Sep. 26, 2023, 26 pages. [cited by applicant]
UPSTO, Final Office Action for U.S. Appl. No. 17/743,213, Jun. 14, 2023, 29 pages. [cited by applicant]
UPSTO, Non-final Office Action for U.S. Appl. No. 17/743,249, Feb. 8, 2023, 30 pages. [cited by applicant]
UPSTO, Non-final Office Action for U.S. Appl. No. 17/743,213, Jan. 26, 2023, 30 pages. [cited by applicant]
UPSTO, Notice of Allowance for U.S. Design U.S. Appl. No. 29/558,312, Mar. 8, 2017, 5 pages. [cited by applicant]
UPSTO, Non-final Office Action for U.S. Appl. No. 15/245,042, Oct. 11, 2016, 6 pages. [cited by applicant]
UPSTO, Notice of Allowance for U.S. Appl. No. 16/792,748, Aug. 30, 2023, 7 pages. [cited by applicant]
UPSTO, Ex Parte Quayle Action for U.S. Appl. No. 17/743,249, Jun. 27, 2023, 7 pages. [cited by applicant]
UPSTO, Non-final Office Action for U.S. Appl. No. 19/321,997, Dec. 18, 2025, 30 pages. [cited by applicant]